Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of topical ionic contra-viral therapy (digoxin + furosemide) in actinic keratosis
2018-000034-36Phase 2Completed
- Sponsor
- Biofrontera
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in actinic keratosis (AK) comparing Topical ICVT (digoxin + furosemide) with Topical vehicle control (2 arms). Primary endpoints: Efficacy endpoints, Pharmacodynamic endpoints and 1 more. Started Jul 2018; status: completed.
02
Drugs
digoxinfurosemide
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2018-000034-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000034-36.